Topics

FDA authorizes marketing of first next-generation sequencing test for detecting HIV-1 drug resistance mutations

09:32 EST 5 Nov 2019 | FDA

Today, the FDA authorized marketing of a test to detect human immunodeficiency virus (HIV) Type-1 drug resistance mutations using next generation sequencing (NGS) technology. It is the first HIV drug resistance assay that uses NGS that the FDA has authorized for marketing in the U.S.

Original Article: FDA authorizes marketing of first next-generation sequencing test for detecting HIV-1 drug resistance mutations

NEXT ARTICLE

More From BioPortfolio on "FDA authorizes marketing of first next-generation sequencing test for detecting HIV-1 drug resistance mutations"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

AIDS and HIV
AIDS; Acquired Immune Deficiency Syndrome. HIV; Human Immunodeficiency Virus HIV infection causes AIDS. HIV infection also causes the production of anti-HIV antibodies, which forms the test for HIV in patients. People who have the HIV antibodies are ...